Stromer, Waltraud
Pabinger, Ingrid
Ay, Cihan
Crevenna, Richard
Donnerer, Josef
Feistritzer, Clemens
Hemberger, Sophie
Likar, Rudolf
Sevelda, Florian
Thom, Katharina
Wagner, Barbara
Streif, Werner
Funding for this research was provided by:
Shire/Takeda Austria
University of Innsbruck and Medical University of Innsbruck
Article History
Received: 17 August 2020
Accepted: 11 December 2020
First Online: 4 March 2021
Conflict of interest
: W. Stromer, R. Crevenna, J. Donnerer, C. Feistritzer, S. Hemberger, R. Likar, F. Sevelda, K. Thom, B. Wagner and W. Streif declare that they have no competing interests. I. Pabinger received fees for occasional lectures and advisory board meetings from Bayer, Biotest, CSL Behring, Novo Nordisk, Pfizer, Roche, Sobi. C. Ay received personal fees from Shire/Takeda, Bayer, CSL Behring, Octapharma, Roche and Sobi for lectures and/or participation in advisory boards.